{
  "TP53": [
    {
      "cosmic_id": "COSM10656",
      "gene": "TP53",
      "variant": "c.524G>A",
      "protein_change": "p.R175H",
      "cancer_types": [
        "lung",
        "breast",
        "colorectal",
        "ovarian",
        "sarcoma"
      ],
      "sample_count": 8924,
      "mutation_frequency": 4.2,
      "tier": "Tier 1",
      "resistance_mutations": [
        "TP53_LOH",
        "MDM2_amplification"
      ],
      "therapeutic_targets": [
        "APR-246",
        "PRIMA-1MET",
        "nutlin-3"
      ],
      "evidence_level": "strong",
      "fda_approved": false,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM10656",
      "oncogenic": true,
      "hypermutator": false
    },
    {
      "cosmic_id": "COSM10679",
      "gene": "TP53",
      "variant": "c.818G>A",
      "protein_change": "p.R273H",
      "cancer_types": [
        "breast",
        "colorectal",
        "lung",
        "ovarian"
      ],
      "sample_count": 6234,
      "mutation_frequency": 2.9,
      "tier": "Tier 1",
      "resistance_mutations": [
        "MDM2_amplification"
      ],
      "therapeutic_targets": [
        "APR-246",
        "statins"
      ],
      "evidence_level": "strong",
      "fda_approved": false,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM10679",
      "oncogenic": true,
      "hypermutator": false
    },
    {
      "cosmic_id": "COSM10660",
      "gene": "TP53",
      "variant": "c.733G>A",
      "protein_change": "p.G245S",
      "cancer_types": [
        "lung",
        "colorectal",
        "breast"
      ],
      "sample_count": 2156,
      "mutation_frequency": 1.0,
      "tier": "Tier 1",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "APR-246"
      ],
      "evidence_level": "strong",
      "fda_approved": false,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM10660",
      "oncogenic": true,
      "hypermutator": false
    },
    {
      "cosmic_id": "COSM10665",
      "gene": "TP53",
      "variant": "c.844C>T",
      "protein_change": "p.R282W",
      "cancer_types": [
        "lung",
        "breast",
        "colorectal"
      ],
      "sample_count": 1847,
      "mutation_frequency": 0.9,
      "tier": "Tier 1",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "APR-246"
      ],
      "evidence_level": "strong",
      "fda_approved": false,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM10665",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "KRAS": [
    {
      "cosmic_id": "COSM516",
      "gene": "KRAS",
      "variant": "c.34G>T",
      "protein_change": "p.G12C",
      "cancer_types": [
        "lung",
        "colorectal",
        "pancreatic"
      ],
      "sample_count": 15678,
      "mutation_frequency": 13.1,
      "tier": "Tier 1",
      "resistance_mutations": [
        "KRAS_amplification",
        "SHP2_mutations",
        "RTK_amplification"
      ],
      "therapeutic_targets": [
        "sotorasib",
        "adagrasib",
        "MRTX849"
      ],
      "evidence_level": "strong",
      "fda_approved": true,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM516",
      "oncogenic": true,
      "hypermutator": false
    },
    {
      "cosmic_id": "COSM521",
      "gene": "KRAS",
      "variant": "c.35G>A",
      "protein_change": "p.G12D",
      "cancer_types": [
        "pancreatic",
        "colorectal",
        "lung"
      ],
      "sample_count": 18234,
      "mutation_frequency": 47.3,
      "tier": "Tier 1",
      "resistance_mutations": [
        "KRAS_amplification"
      ],
      "therapeutic_targets": [
        "MRTX1133",
        "experimental_G12D_inhibitors"
      ],
      "evidence_level": "strong",
      "fda_approved": false,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM521",
      "oncogenic": true,
      "hypermutator": false
    },
    {
      "cosmic_id": "COSM517",
      "gene": "KRAS",
      "variant": "c.35G>T",
      "protein_change": "p.G12V",
      "cancer_types": [
        "lung",
        "colorectal",
        "bladder"
      ],
      "sample_count": 9876,
      "mutation_frequency": 21.2,
      "tier": "Tier 1",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "experimental_G12V_inhibitors",
        "MRTX1133"
      ],
      "evidence_level": "strong",
      "fda_approved": false,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM517",
      "oncogenic": true,
      "hypermutator": false
    },
    {
      "cosmic_id": "COSM532",
      "gene": "KRAS",
      "variant": "c.37G>T",
      "protein_change": "p.G13D",
      "cancer_types": [
        "colorectal",
        "lung",
        "pancreatic"
      ],
      "sample_count": 5432,
      "mutation_frequency": 8.7,
      "tier": "Tier 2",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "experimental_inhibitors"
      ],
      "evidence_level": "moderate",
      "fda_approved": false,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM532",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "EGFR": [
    {
      "cosmic_id": "COSM6224",
      "gene": "EGFR",
      "variant": "c.2573T>G",
      "protein_change": "p.L858R",
      "cancer_types": [
        "lung_adenocarcinoma"
      ],
      "sample_count": 5432,
      "mutation_frequency": 8.2,
      "tier": "Tier 1",
      "resistance_mutations": [
        "T790M",
        "C797S",
        "L792F",
        "MET_amplification"
      ],
      "therapeutic_targets": [
        "osimertinib",
        "erlotinib",
        "gefitinib",
        "afatinib"
      ],
      "evidence_level": "strong",
      "fda_approved": true,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM6224",
      "oncogenic": true,
      "hypermutator": false
    },
    {
      "cosmic_id": "COSM6240",
      "gene": "EGFR",
      "variant": "c.2369C>T",
      "protein_change": "p.T790M",
      "cancer_types": [
        "lung_adenocarcinoma"
      ],
      "sample_count": 3421,
      "mutation_frequency": 50.2,
      "tier": "Tier 1",
      "resistance_mutations": [
        "C797S",
        "MET_amplification"
      ],
      "therapeutic_targets": [
        "osimertinib"
      ],
      "evidence_level": "strong",
      "fda_approved": true,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": "acquired_resistance_to_1st_gen_TKI",
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM6240",
      "oncogenic": true,
      "hypermutator": false
    },
    {
      "cosmic_id": "COSM6213",
      "gene": "EGFR",
      "variant": "c.2156G>C",
      "protein_change": "p.G719C",
      "cancer_types": [
        "lung_adenocarcinoma"
      ],
      "sample_count": 1234,
      "mutation_frequency": 1.2,
      "tier": "Tier 1",
      "resistance_mutations": [
        "T790M"
      ],
      "therapeutic_targets": [
        "afatinib",
        "osimertinib"
      ],
      "evidence_level": "strong",
      "fda_approved": false,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM6213",
      "oncogenic": true,
      "hypermutator": false
    },
    {
      "cosmic_id": "COSM6241",
      "gene": "EGFR",
      "variant": "c.2390C>T",
      "protein_change": "p.C797S",
      "cancer_types": [
        "lung_adenocarcinoma"
      ],
      "sample_count": 567,
      "mutation_frequency": 25.1,
      "tier": "Tier 1",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "4th_generation_TKIs"
      ],
      "evidence_level": "strong",
      "fda_approved": false,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": "acquired_resistance_to_osimertinib",
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM6241",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "PIK3CA": [
    {
      "cosmic_id": "COSM775",
      "gene": "PIK3CA",
      "variant": "c.3140A>G",
      "protein_change": "p.H1047R",
      "cancer_types": [
        "breast",
        "colorectal",
        "endometrial"
      ],
      "sample_count": 6789,
      "mutation_frequency": 18.2,
      "tier": "Tier 1",
      "resistance_mutations": [
        "PI3K_pathway_mutations"
      ],
      "therapeutic_targets": [
        "alpelisib",
        "capivasertib"
      ],
      "evidence_level": "strong",
      "fda_approved": true,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM775",
      "oncogenic": true,
      "hypermutator": false
    },
    {
      "cosmic_id": "COSM763",
      "gene": "PIK3CA",
      "variant": "c.1633G>A",
      "protein_change": "p.E545K",
      "cancer_types": [
        "breast",
        "colorectal",
        "lung"
      ],
      "sample_count": 4567,
      "mutation_frequency": 8.3,
      "tier": "Tier 1",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "alpelisib",
        "capivasertib"
      ],
      "evidence_level": "strong",
      "fda_approved": false,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM763",
      "oncogenic": true,
      "hypermutator": false
    },
    {
      "cosmic_id": "COSM754",
      "gene": "PIK3CA",
      "variant": "c.1624G>A",
      "protein_change": "p.E542K",
      "cancer_types": [
        "breast",
        "colorectal",
        "endometrial"
      ],
      "sample_count": 3456,
      "mutation_frequency": 6.1,
      "tier": "Tier 1",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "alpelisib"
      ],
      "evidence_level": "strong",
      "fda_approved": false,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM754",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "BRAF": [
    {
      "cosmic_id": "COSM476",
      "gene": "BRAF",
      "variant": "c.1799T>A",
      "protein_change": "p.V600E",
      "cancer_types": [
        "melanoma",
        "thyroid",
        "colorectal",
        "lung"
      ],
      "sample_count": 12345,
      "mutation_frequency": 40.2,
      "tier": "Tier 1",
      "resistance_mutations": [
        "NRAS_mutations",
        "MEK_mutations",
        "RTK_amplification"
      ],
      "therapeutic_targets": [
        "vemurafenib",
        "dabrafenib",
        "encorafenib"
      ],
      "evidence_level": "strong",
      "fda_approved": true,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM476",
      "oncogenic": true,
      "hypermutator": false
    },
    {
      "cosmic_id": "COSM478",
      "gene": "BRAF",
      "variant": "c.1798_1799GT>AA",
      "protein_change": "p.V600K",
      "cancer_types": [
        "melanoma",
        "lung"
      ],
      "sample_count": 2134,
      "mutation_frequency": 8.1,
      "tier": "Tier 1",
      "resistance_mutations": [
        "NRAS_mutations"
      ],
      "therapeutic_targets": [
        "dabrafenib",
        "vemurafenib"
      ],
      "evidence_level": "strong",
      "fda_approved": false,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM478",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "IDH1": [
    {
      "cosmic_id": "COSM28746",
      "gene": "IDH1",
      "variant": "c.395G>A",
      "protein_change": "p.R132H",
      "cancer_types": [
        "glioma",
        "acute_myeloid_leukemia"
      ],
      "sample_count": 3456,
      "mutation_frequency": 85.1,
      "tier": "Tier 1",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "ivosidenib"
      ],
      "evidence_level": "strong",
      "fda_approved": true,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM28746",
      "oncogenic": true,
      "hypermutator": false
    },
    {
      "cosmic_id": "COSM28748",
      "gene": "IDH1",
      "variant": "c.394C>T",
      "protein_change": "p.R132C",
      "cancer_types": [
        "glioma",
        "acute_myeloid_leukemia"
      ],
      "sample_count": 567,
      "mutation_frequency": 3.2,
      "tier": "Tier 1",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "ivosidenib"
      ],
      "evidence_level": "strong",
      "fda_approved": false,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM28748",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "IDH2": [
    {
      "cosmic_id": "COSM41590",
      "gene": "IDH2",
      "variant": "c.515G>A",
      "protein_change": "p.R172K",
      "cancer_types": [
        "acute_myeloid_leukemia",
        "glioma"
      ],
      "sample_count": 1234,
      "mutation_frequency": 12.3,
      "tier": "Tier 1",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "enasidenib"
      ],
      "evidence_level": "strong",
      "fda_approved": true,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM41590",
      "oncogenic": true,
      "hypermutator": false
    },
    {
      "cosmic_id": "COSM41591",
      "gene": "IDH2",
      "variant": "c.514A>G",
      "protein_change": "p.R172G",
      "cancer_types": [
        "acute_myeloid_leukemia"
      ],
      "sample_count": 345,
      "mutation_frequency": 3.4,
      "tier": "Tier 1",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "enasidenib"
      ],
      "evidence_level": "strong",
      "fda_approved": false,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM41591",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "KIT": [
    {
      "cosmic_id": "COSM1314",
      "gene": "KIT",
      "variant": "c.1727T>A",
      "protein_change": "p.D816V",
      "cancer_types": [
        "mastocytosis",
        "acute_myeloid_leukemia"
      ],
      "sample_count": 567,
      "mutation_frequency": 92.3,
      "tier": "Tier 1",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "midostaurin",
        "avapritinib"
      ],
      "evidence_level": "strong",
      "fda_approved": true,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM1314",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "FLT3": [
    {
      "cosmic_id": "COSM12866",
      "gene": "FLT3",
      "variant": "c.1773_1774insGATGTCTA",
      "protein_change": "p.591_592ins",
      "cancer_types": [
        "acute_myeloid_leukemia"
      ],
      "sample_count": 2345,
      "mutation_frequency": 23.1,
      "tier": "Tier 1",
      "resistance_mutations": [
        "FLT3_secondary_mutations"
      ],
      "therapeutic_targets": [
        "midostaurin",
        "gilteritinib",
        "quizartinib"
      ],
      "evidence_level": "strong",
      "fda_approved": true,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM12866",
      "oncogenic": true,
      "hypermutator": false
    },
    {
      "cosmic_id": "COSM769",
      "gene": "FLT3",
      "variant": "c.2503G>A",
      "protein_change": "p.D835Y",
      "cancer_types": [
        "acute_myeloid_leukemia"
      ],
      "sample_count": 456,
      "mutation_frequency": 7.2,
      "tier": "Tier 1",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "gilteritinib",
        "crenolanib"
      ],
      "evidence_level": "strong",
      "fda_approved": false,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM769",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "NRAS": [
    {
      "cosmic_id": "COSM584",
      "gene": "NRAS",
      "variant": "c.182A>G",
      "protein_change": "p.Q61R",
      "cancer_types": [
        "melanoma",
        "thyroid",
        "colorectal"
      ],
      "sample_count": 2345,
      "mutation_frequency": 15.2,
      "tier": "Tier 2",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "trametinib",
        "cobimetinib"
      ],
      "evidence_level": "moderate",
      "fda_approved": false,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM584",
      "oncogenic": true,
      "hypermutator": false
    },
    {
      "cosmic_id": "COSM583",
      "gene": "NRAS",
      "variant": "c.181C>A",
      "protein_change": "p.Q61K",
      "cancer_types": [
        "melanoma",
        "colorectal"
      ],
      "sample_count": 1876,
      "mutation_frequency": 8.7,
      "tier": "Tier 2",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "MEK_inhibitors"
      ],
      "evidence_level": "moderate",
      "fda_approved": false,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM583",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "BRCA1": [
    {
      "cosmic_id": "COSM12345",
      "gene": "BRCA1",
      "variant": "c.68_69delAG",
      "protein_change": "p.E23fs",
      "cancer_types": [
        "breast",
        "ovarian"
      ],
      "sample_count": 1234,
      "mutation_frequency": 1.2,
      "tier": "Tier 1",
      "resistance_mutations": [
        "BRCA1_reversion",
        "P53BP1_loss"
      ],
      "therapeutic_targets": [
        "olaparib",
        "talazoparib",
        "rucaparib",
        "niraparib"
      ],
      "evidence_level": "strong",
      "fda_approved": true,
      "hotspot": false,
      "founder_mutation": true,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM12345",
      "oncogenic": true,
      "hypermutator": false
    },
    {
      "cosmic_id": "COSM12346",
      "gene": "BRCA1",
      "variant": "c.5266dupC",
      "protein_change": "p.Q1756fs",
      "cancer_types": [
        "breast",
        "ovarian"
      ],
      "sample_count": 876,
      "mutation_frequency": 0.8,
      "tier": "Tier 1",
      "resistance_mutations": [
        "BRCA1_reversion"
      ],
      "therapeutic_targets": [
        "olaparib",
        "talazoparib"
      ],
      "evidence_level": "strong",
      "fda_approved": false,
      "hotspot": false,
      "founder_mutation": true,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM12346",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "BRCA2": [
    {
      "cosmic_id": "COSM12347",
      "gene": "BRCA2",
      "variant": "c.5946delT",
      "protein_change": "p.S1982fs",
      "cancer_types": [
        "breast",
        "ovarian",
        "prostate",
        "pancreatic"
      ],
      "sample_count": 1567,
      "mutation_frequency": 1.4,
      "tier": "Tier 1",
      "resistance_mutations": [
        "BRCA2_reversion"
      ],
      "therapeutic_targets": [
        "olaparib",
        "talazoparib",
        "rucaparib"
      ],
      "evidence_level": "strong",
      "fda_approved": true,
      "hotspot": false,
      "founder_mutation": true,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM12347",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "ALK": [
    {
      "cosmic_id": "COSM1565",
      "gene": "ALK",
      "variant": "c.3522C>G",
      "protein_change": "EML4-ALK_fusion",
      "cancer_types": [
        "lung_adenocarcinoma"
      ],
      "sample_count": 890,
      "mutation_frequency": 4.2,
      "tier": "Tier 1",
      "resistance_mutations": [
        "ALK_secondary_mutations",
        "bypass_mechanisms"
      ],
      "therapeutic_targets": [
        "crizotinib",
        "alectinib",
        "ceritinib",
        "brigatinib"
      ],
      "evidence_level": "strong",
      "fda_approved": true,
      "hotspot": false,
      "founder_mutation": false,
      "fusion": true,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM1565",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "ROS1": [
    {
      "cosmic_id": "COSM1566",
      "gene": "ROS1",
      "variant": "c.6008_6009insGTGTGTGCCAGCCAG",
      "protein_change": "CD74-ROS1_fusion",
      "cancer_types": [
        "lung_adenocarcinoma"
      ],
      "sample_count": 234,
      "mutation_frequency": 1.8,
      "tier": "Tier 1",
      "resistance_mutations": [
        "ROS1_secondary_mutations"
      ],
      "therapeutic_targets": [
        "crizotinib",
        "entrectinib",
        "ceritinib"
      ],
      "evidence_level": "strong",
      "fda_approved": true,
      "hotspot": false,
      "founder_mutation": false,
      "fusion": true,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM1566",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "RET": [
    {
      "cosmic_id": "COSM1567",
      "gene": "RET",
      "variant": "c.2944G>A",
      "protein_change": "KIF5B-RET_fusion",
      "cancer_types": [
        "lung_adenocarcinoma",
        "thyroid"
      ],
      "sample_count": 345,
      "mutation_frequency": 1.2,
      "tier": "Tier 1",
      "resistance_mutations": [
        "RET_gatekeeper_mutations"
      ],
      "therapeutic_targets": [
        "selpercatinib",
        "pralsetinib"
      ],
      "evidence_level": "strong",
      "fda_approved": true,
      "hotspot": false,
      "founder_mutation": false,
      "fusion": true,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM1567",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "MET": [
    {
      "cosmic_id": "COSM1568",
      "gene": "MET",
      "variant": "c.3082+1G>A",
      "protein_change": "exon14_skipping",
      "cancer_types": [
        "lung_adenocarcinoma"
      ],
      "sample_count": 456,
      "mutation_frequency": 3.1,
      "tier": "Tier 1",
      "resistance_mutations": [
        "MET_amplification",
        "MET_secondary_mutations"
      ],
      "therapeutic_targets": [
        "capmatinib",
        "tepotinib"
      ],
      "evidence_level": "strong",
      "fda_approved": true,
      "hotspot": false,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": true,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM1568",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "ERBB2": [
    {
      "cosmic_id": "COSM1569",
      "gene": "ERBB2",
      "variant": "c.2524G>A",
      "protein_change": "p.V842I",
      "cancer_types": [
        "lung_adenocarcinoma",
        "breast"
      ],
      "sample_count": 234,
      "mutation_frequency": 2.1,
      "tier": "Tier 2",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "trastuzumab",
        "pertuzumab",
        "T-DM1"
      ],
      "evidence_level": "moderate",
      "fda_approved": false,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM1569",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "KRASG12A": [
    {
      "cosmic_id": "COSM518",
      "gene": "KRASG12A",
      "variant": "c.35G>C",
      "protein_change": "p.G12A",
      "cancer_types": [
        "lung",
        "colorectal"
      ],
      "sample_count": 1234,
      "mutation_frequency": 2.3,
      "tier": "Tier 2",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "experimental_inhibitors"
      ],
      "evidence_level": "moderate",
      "fda_approved": false,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM518",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "SMARCB1": [
    {
      "cosmic_id": "COSM1570",
      "gene": "SMARCB1",
      "variant": "c.1A>G",
      "protein_change": "p.M1V",
      "cancer_types": [
        "rhabdoid_tumor",
        "epithelioid_sarcoma"
      ],
      "sample_count": 123,
      "mutation_frequency": 95.2,
      "tier": "Tier 3",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "EZH2_inhibitors",
        "BRD4_inhibitors"
      ],
      "evidence_level": "emerging",
      "fda_approved": false,
      "hotspot": false,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM1570",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "PTCH1": [
    {
      "cosmic_id": "COSM1571",
      "gene": "PTCH1",
      "variant": "c.2806C>T",
      "protein_change": "p.Q936*",
      "cancer_types": [
        "basal_cell_carcinoma",
        "medulloepithelioma"
      ],
      "sample_count": 234,
      "mutation_frequency": 67.8,
      "tier": "Tier 2",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "vismodegib",
        "sonidegib"
      ],
      "evidence_level": "moderate",
      "fda_approved": true,
      "hotspot": false,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM1571",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "SMO": [
    {
      "cosmic_id": "COSM1572",
      "gene": "SMO",
      "variant": "c.1604G>A",
      "protein_change": "p.W535L",
      "cancer_types": [
        "basal_cell_carcinoma"
      ],
      "sample_count": 89,
      "mutation_frequency": 12.3,
      "tier": "Tier 2",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "vismodegib",
        "sonidegib"
      ],
      "evidence_level": "moderate",
      "fda_approved": false,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM1572",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "FGFR2": [
    {
      "cosmic_id": "COSM1573",
      "gene": "FGFR2",
      "variant": "c.758C>G",
      "protein_change": "p.S253W",
      "cancer_types": [
        "endometrial",
        "bladder"
      ],
      "sample_count": 456,
      "mutation_frequency": 8.9,
      "tier": "Tier 2",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "erdafitinib",
        "infigratinib"
      ],
      "evidence_level": "moderate",
      "fda_approved": false,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM1573",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "FGFR3": [
    {
      "cosmic_id": "COSM1574",
      "gene": "FGFR3",
      "variant": "c.746C>G",
      "protein_change": "p.R249G",
      "cancer_types": [
        "bladder",
        "multiple_myeloma"
      ],
      "sample_count": 678,
      "mutation_frequency": 15.4,
      "tier": "Tier 2",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "erdafitinib"
      ],
      "evidence_level": "moderate",
      "fda_approved": true,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM1574",
      "oncogenic": true,
      "hypermutator": false
    }
  ],
  "POLE": [
    {
      "cosmic_id": "COSM1575",
      "gene": "POLE",
      "variant": "c.857C>G",
      "protein_change": "p.P286R",
      "cancer_types": [
        "endometrial",
        "colorectal"
      ],
      "sample_count": 234,
      "mutation_frequency": 7.2,
      "tier": "Tier 2",
      "resistance_mutations": [],
      "therapeutic_targets": [
        "immunotherapy",
        "checkpoint_inhibitors"
      ],
      "evidence_level": "moderate",
      "fda_approved": false,
      "hotspot": true,
      "founder_mutation": false,
      "fusion": false,
      "splice_variant": false,
      "resistance_context": null,
      "cosmic_url": "https://cancer.sanger.ac.uk/cosmic/mutation/overview?id=COSM1575",
      "oncogenic": true,
      "hypermutator": true
    }
  ]
}